-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Beam Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
- Beam Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $13.9M, a 28.3% decline year-over-year.
- Beam Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $42.8M, a 48.5% decline year-over-year.
- Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $45.3M, a 42.1% decline from 2022.
- Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $78.3M, a 259% increase from 2021.
- Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $21.8M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)